Bioactive Wound Dressing Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| CAGR | 11.00 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Bioactive Wound Dressing Market Analysis
The bioactive wound dressing market is expected to register a CAGR of 11% during the forecast period.
The COVID-19 outbreak impacted the bioactive wound dressing market and the overall healthcare sector, as hospitals and healthcare services were reduced due to social distancing measures taken by governments worldwide. The COVID-19 pandemic affected the global economy and greatly impacted the functioning of general hospital care for non-COVID-19 patients in hospitals globally. The article presented by UpToDate Inc., updated in June 2022, indicated that the delivery of wound care, which should be regarded as an essential medical service, shifted during the COVID-19 pandemic. During the pandemic, significant importance was placed on wound care to prevent serious wound complications by minimizing hospitalization and surgery rather than completing wound healing. The reduction in the available bioactive wound dressing services was adversely impacted by the COVID-19 pandemic but has recovered in the two years to post strong growth.
The bioactive wound dressing market is driven by advancements in technology, the growing aging population, the rising burden of chronic wounds, and problems associated with conventional wound healing procedures. An article published in the Journal of Advances in Wound Care in March 2021 indicated that chronic wounds impact the quality of life (QoL) of nearly 2.5% of the US population and that wound care management has an important economic impact on the US healthcare sector. Chronic wounds are most commonly seen in the elderly population of the nation. With the growing geriatric population in the United States, the incidence of chronic wounds is expected to increase, thereby aiding the growth of the market studied. According to the World Bank Report 2022, there were 11,075 surgical procedures (per 100,000 population) in the European Union. The rising number of surgeries in Europe has been directly contributing to the growth of the market studied in the long run, as wounds have also been increasing due to surgeries. Therefore, with the rising volume of surgical procedures, the market studied is expected to grow over the forecast period.
However, the high cost of treatment and unfavorable reimbursement policies are a few factors hindering the growth of the bioactive wound dressing market.
Bioactive Wound Dressing Market Trends
This section covers the major market trends shaping the Bioactive Wound Dressing Market according to our research experts:
Wounds Segment is Expected to Hold a Significant Market Share over the Forecast Period
The increasing cases of different traumatic wounds and burns are one of the major factors driving the adoption of wound dressing. According to the Journal of Surgical Research data published in October 2021, the total number of burn patients recorded was 44,369 in Africa, of which the mean proportion of males was 56%. The most common cause of injury was scalding (61%), followed by open flame (17%). Similarly, WHO data published in January 2022 stated that at least 33 countries with tropical, subtropical, and temperate climates had reported Buruli ulcers in Africa, South America, and Western Pacific regions. Differential diagnoses of Buruli ulcers include tropical phagedenic ulcers and chronic lower leg ulcers due to arterial and venous insufficiency. The lesions due to this disease occur 35% on the upper limbs, 55% on the lower limbs, and 10% on other parts of the body. Such statistics indicate that the wounds segment is expected to witness notable growth in the near future.
Moreover, rising initiatives by key players in the market to grow their presence is another factor in the market's growth. For instance, in January 2022, Triad Life Sciences Inc. entered into a formal agreement to be acquired by Convatec Group PLC to address unmet clinical requirements in surgical wounds, chronic wounds, and burns.
Hence, owing to the aforementioned factors, the segment is expected to witness significant growth over the forecast period.
North America is Expected to Witness Healthy Growth over the Forecast Period
The North American bioactive wound dressing market is projected to have a significant market share worldwide. The major factors driving the market in the region are the rapidly growing aging population, the high diabetic population, and the developed healthcare system, which adapts to novel innovations. The prevalence of diabetes has increased in recent years, and many reports have predicted this prevalence to increase further in the future. For instance, according to the International Diabetes Federation Diabetes Atlas Tenth edition, in 2021, around 32.2 million people in the United States had diabetes, and this is projected to grow to 36.3 million by 2045. As per the Canadian Diabetes Association (CDA), in 2021, there were around 11.5 million people in Canada diagnosed with diabetes. As of 2021, around 29% of the Canadian population was estimated to be susceptible to diabetes, which included both diagnosed and undiagnosed cases. The rising number of diabetic cases in the nation is expected to increase the number of diabetic ulcer cases. Similarly, an article published in the Journal of Foot in February 2022 indicated that nearly 67% of leg amputations in the United States are associated with diabetes. Many cases of diabetic foot ulcers in the nation are likely to propel the market's growth. Thus, owing to the aforementioned factors, the segment is expected to show significant growth over the forecast period.
Bioactive Wound Dressing Industry Overview
The bioactive wound dressing market is moderately fragmented and competitive. The key market players include 3M, Convatec Group PLC, Monlnlycke Health Care AB, Smith & Nephew PLC, and B. Braun SE, among others. Furthermore, companies focus on industry collaborations, mergers, acquisitions, and partnerships to enhance their presence in the market studied.
Bioactive Wound Dressing Market Leaders
-
3M
-
B. Braun SE
-
Convatec Group PLC
-
Monlnlycke Health Care AB
-
Smith & Nephew PLC
*Disclaimer: Major Players sorted in no particular order
Bioactive Wound Dressing Market News
- October 2022: Scaffold, a novel bandage solution developed by Queen's University Belfast researchers, was released to treat diabetic foot ulcers. It is both affordable and effective for patients.
- June 2022: Medline launched a new version of its Optifoam Gentle EX Foam dressing. Medline's Optifoam Gentle EX dressing is a key product in the company's Skin Health Solution Program, a holistic approach to skin and wound care focused on people, processes, and products.
Bioactive Wound Dressing Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Growing Burden of Chronic Wounds and Associated Diseases
- 4.2.2 Advancements in Bioactive Wound Dressings
-
4.3 Market Restraints
- 4.3.1 Lack of Proper Reimbursement
-
4.4 Porter's Five Force Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD million)
-
5.1 By Product
- 5.1.1 Hydrocolloids
- 5.1.2 Alginate Dressing
- 5.1.3 Skin Substitutes
- 5.1.4 Antimicrobial Dressing
- 5.1.5 Other Products
-
5.2 By Application
- 5.2.1 Wounds
- 5.2.2 Burns
- 5.2.3 Ulcers
- 5.2.4 Other Applications
-
5.3 Geography
- 5.3.1 North America
- 5.3.1.1 United States
- 5.3.1.2 Canada
- 5.3.1.3 Mexico
- 5.3.2 Europe
- 5.3.2.1 Germany
- 5.3.2.2 United Kingdom
- 5.3.2.3 France
- 5.3.2.4 Italy
- 5.3.2.5 Spain
- 5.3.2.6 Rest of Europe
- 5.3.3 Asia-Pacific
- 5.3.3.1 China
- 5.3.3.2 Japan
- 5.3.3.3 India
- 5.3.3.4 Australia
- 5.3.3.5 South Korea
- 5.3.3.6 Rest of Asia-Pacific
- 5.3.4 Middle East and Africa
- 5.3.4.1 GCC
- 5.3.4.2 South Africa
- 5.3.4.3 Rest of Middle East and Africa
- 5.3.5 South America
- 5.3.5.1 Brazil
- 5.3.5.2 Argentina
- 5.3.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 3M
- 6.1.2 B. Braun SE
- 6.1.3 BSN Medical (Essity)
- 6.1.4 Convatec Group PLC
- 6.1.5 Covalon Technologies Ltd
- 6.1.6 DermaRite Industries LLC
- 6.1.7 Hollister Incorporated
- 6.1.8 Integra LifeSciences Holdings Corporation
- 6.1.9 Johnson & Johnson
- 6.1.10 Medtronic PLC
- 6.1.11 Monlnlycke Health Care AB
- 6.1.12 Smith & Nephew PLC
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityBioactive Wound Dressing Industry Segmentation
As per the scope, bioactive dressings are those that either supply bioactive molecules directly to the wound or are made from materials with endogenous activity. These substances include bio textiles, alginates, collagens, chitosan, chitin, and derivatives of those substances. In bioactive wound care, the dressing is different from the normal bandage and is designed specially to stay in direct contact with the wound.
The bioactive wound dressing market is segmented by product (hydrocolloids, alginate dressing, skin substitutes, antimicrobial dressing, and other products), application (wounds, burns, ulcers, and other applications), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across the major regions globally. The report offers the values (USD million) for the above segments.
| By Product | Hydrocolloids | |
| Alginate Dressing | ||
| Skin Substitutes | ||
| Antimicrobial Dressing | ||
| Other Products | ||
| By Application | Wounds | |
| Burns | ||
| Ulcers | ||
| Other Applications | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Geography | Europe | Germany |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| Geography | Asia-Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| Geography | Middle East and Africa | GCC |
| South Africa | ||
| Rest of Middle East and Africa | ||
| Geography | South America | Brazil |
| Argentina | ||
| Rest of South America |
Bioactive Wound Dressing Market Research FAQs
What is the current Bioactive Wound Dressing Market size?
The Bioactive Wound Dressing Market is projected to register a CAGR of 11% during the forecast period (2024-2029)
Who are the key players in Bioactive Wound Dressing Market?
3M, B. Braun SE, Convatec Group PLC, Monlnlycke Health Care AB and Smith & Nephew PLC are the major companies operating in the Bioactive Wound Dressing Market.
Which is the fastest growing region in Bioactive Wound Dressing Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Bioactive Wound Dressing Market?
In 2024, the North America accounts for the largest market share in Bioactive Wound Dressing Market.
What years does this Bioactive Wound Dressing Market cover?
The report covers the Bioactive Wound Dressing Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Bioactive Wound Dressing Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Bioactive Wound Dressing Industry Report
Statistics for the 2024 Bioactive Wound Dressing market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Bioactive Wound Dressing analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
